Lilly CEO: Monoclonal Antibody Companies Should Share Coronavirus Manufacturing Capacity

David Ricks says a consortium of companies will be needed to ensure enough doses of the successful candidates are available.

Coronavirus globe
Monoclonal antibody treatment and manufacturing on the scale of a global pandemic has never been tried before, Lilly CEO David Ricks said. • Source: Shutterstock

Monoclonal antibody development as a coronavirus treatment may require global manufacturing cooperation, similar to those established for vaccines.

Eli Lilly & Co. Chairman and CEO David Ricks said that should a monoclonal antibody be proven safe and...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance